A big bang Pharma IPO: What is set to be the pharma industry's biggest IPO in a decade is coming up in early 2017, with Eris LifeSciences' Rs. 2000 crore IPO. The company, which figures in the top six in India for treating diabetes and high blood pressure, is seeking a Rs. 10,000 crore valuation. Eris currently clocks revenues of Rs. 800 crore and profits of Rs. 200 crore. 

Not a happy Dussehra: there are some dismal second-quarter results are coming up for India's IT services companies, as everyone from TCS, Infosys and the smaller players are hit by weak spending, pricing pressures and automated offerings that are taking a big bite out of the IT services pie. The second-quarter is usually the better-performing quarter of the financial year, and this therefore does not bode well for yearly results. Infosys, which has already lowered its guidance once, is expected to do so again. Infosys has seen 5 price downgrades from brokerages in recent months, and TCS has seen three downgrades in the last month alone. 

Repco Home Finance is the latest company to come under scrutiny by the CBI, with the agency searching company and home premises of directors after allegations of favoritism to some customers. The company insists that regulations were followed: the allegations are apparently regarding a Rs. 6 crore loan taken by a Coimbatore-based firm. 

Amid recriminations, anger from telecom rivals, Reliance Jio has claimed a 'world record' in crossing 16 million subscribers in its first month. However, it remains to be seen if these subscribers stay on after the free data services expire in three months. 

Photo of the day: India's indigenous fighter jet Tejas steals the show on Air Force Day. The maneuvers included the aircraft standing vertical in the air, loops and low-speed turns. Firstpost/Naresh Sharma